![Scott Moomaw](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Scott Moomaw
Corporate Officer/Principal bei
LIQUIDIA CORPORATION
Vermögen: 12 Mio $ am 31.08.2026
Profil
Scott Moomaw was the founder of Liquidia PAH LLC, founded in 2018, where the title held was Chief Operating Officer from 2018 to 2020.
The current job is at Liquidia Corp.
starting in 2020, with the title Chief Commercial Officer beginning in 2023.
Former jobs include Associate Vice President-Marketing at United Therapeutics Corp.
from 2011 to 2016 and Vice President-Marketing at OPKO Health, Inc. from 2016 to 2018.
Education includes an undergraduate degree from Miami University and an MBA from the University of Michigan.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LIQUIDIA CORPORATION 0,2 % | 13.07.2026 | 182.485 ( 0,2 % ) | 12 Mio $ | 31.08.2026 |
Aktive Positionen von Scott Moomaw
| Unternehmen | Position | Beginn |
|---|---|---|
| LIQUIDIA CORPORATION | Corporate Officer/Principal | 18.11.2020 |
Ehemalige bekannte Positionen von Scott Moomaw
| Unternehmen | Position | Ende |
|---|---|---|
RareGen LLC
 RareGen LLC Miscellaneous Commercial ServicesCommercial Services Provides investment and commercialization for rare disease pharmaceutical products | Gründer | 01.11.2020 |
| OPKO HEALTH, INC. | Vertrieb & Marketing | 01.08.2018 |
| UNITED THERAPEUTICS CORPORATION | Vertrieb & Marketing | 01.05.2016 |
Ausbildung von Scott Moomaw
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
47
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
United Therapeutics Corp.
 United Therapeutics Corp. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes products to address the unmet medical needs of patients with chronic & life-threatening conditions | Health Technology |
Miami University
 Miami University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OPKO Health, Inc.
 OPKO Health, Inc. Medical/Nursing ServicesHealth Services Engages in biopharmaceutical and diagnostics | Health Services |
RareGen LLC
RareGen LLC Miscellaneous Commercial ServicesCommercial Services Provides investment and commercialization for rare disease pharmaceutical products | Commercial Services |
Liquidia Corp.
 Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
